These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9163064)

  • 1. Thrombin-inhibitor complexes in the blood during and after delivery.
    Andersson T; Lorentzen B; Hogdahl H; Clausen T; Mowinckel MC; Abildgaard U
    Thromb Res; 1996 Apr; 82(2):109-17. PubMed ID: 9163064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heparin cofactor II, a thrombin inhibitor with a still not clarified physiologic role].
    Rossi EB; Duboscq CL; Kordich LC
    Medicina (B Aires); 1999; 59(1):95-104. PubMed ID: 10349131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of thrombin in blood plasma of non-pregnant and pregnant women studied through concentration of thrombin-antithrombin III complexes.
    Uszyński M
    Eur J Obstet Gynecol Reprod Biol; 1997 Dec; 75(2):127-31. PubMed ID: 9447363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues.
    Kamp P; Strathmann A; Ragg H
    Thromb Res; 2001 Mar; 101(6):483-91. PubMed ID: 11323006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sucrose octasulfate selectively accelerates thrombin inactivation by heparin cofactor II.
    Sarilla S; Habib SY; Kravtsov DV; Matafonov A; Gailani D; Verhamme IM
    J Biol Chem; 2010 Mar; 285(11):8278-89. PubMed ID: 20053992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin-antithrombin III complexes and antithrombin III in amniotic fluid.
    Uszyński M; Kielkowski A; Uszyński W; Zekanowska E
    Gynecol Obstet Invest; 1997; 43(1):29-33. PubMed ID: 9015695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of heparin cofactor II (HCII) and thrombin-HCII complex in patients with disseminated intravascular coagulation.
    Noda A; Wada H; Kusiya F; Sakakura M; Onishi K; Nakatani K; Gabazza EC; Asahara N; Tsukada M; Nobori T; Shiku H
    Clin Appl Thromb Hemost; 2002 Jul; 8(3):265-71. PubMed ID: 12361205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
    Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
    Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased heparin cofactor II levels in women taking oral contraceptives.
    Toulon P; Bardin JM; Blumenfeld N
    Thromb Haemost; 1990 Nov; 64(3):365-8. PubMed ID: 2096488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of heparin cofactor II in the modulation of hemostasis.
    Salem HH; Thompson EA
    Dev Biol Stand; 1987; 67():67-72. PubMed ID: 3301469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin cofactor II significance for the inhibition of thrombin at the injured vessel wall.
    Pasche B; Swedenborg J; Frebelius S; Olsson P
    Thromb Res; 1991 Jun; 62(5):409-19. PubMed ID: 1896960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of labor on thrombotic and fibrinolytic systems.
    Yoshimura T; Ito M; Nakamura T; Okamura H
    Eur J Obstet Gynecol Reprod Biol; 1992 May; 44(3):195-9. PubMed ID: 1535054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.
    Kario K; Matsuo T; Kodama K; Matsuo M
    Thromb Res; 1992 Jun; 66(5):509-15. PubMed ID: 1523607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin cofactor II levels are increased by the use of combined oral contraceptives.
    Mackie IJ; Segal H; Burren T; Gallimore M; Walshe KJ; Robinson G; Machin SJ
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):647-51. PubMed ID: 2133244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamic changes and localization of plasma heparin cofactor II before and after delivery in hypertensive pregnancy].
    Chen X; Zhang G; Wang C
    Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):468-70. PubMed ID: 11721410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin-antithrombin III complex levels in normal pregnancy with hypertensive disorders and after delivery.
    Reinthaller A; Mursch-Edlmayr G; Tatra G
    Br J Obstet Gynaecol; 1990 Jun; 97(6):506-10. PubMed ID: 2198919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating serpin-enzyme complex formation and stability via single and multiple residue reactive centre loop substitutions in heparin cofactor II.
    Sutherland JS; Bhakta V; Sheffield WP
    Thromb Res; 2006; 117(4):447-61. PubMed ID: 15869786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation.
    Bellart J; Gilabert R; Fontcuberta J; Carreras E; Miralles RM; Cabero L
    Am J Perinatol; 1998 Feb; 15(2):81-5. PubMed ID: 9514130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.